All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other drugs for disorders of the musculo-skeletal system

Evrysdi

(risdiplam)

Uses, side effects, dosage information & price range

Roche Registration GmbH

About this medicine

Evrysdi is indicated for the treatment of 5q spinal muscular atrophy (SMA) in patients with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies.  

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

ItvismaComposition: onasemnogene abeparvovecNovartis Europharm Limited
Price on RequestView Details →
JelrixComposition: autologous cartilage-derived articular chondrocytes, in-vitro expandedTETEC Tissue Engineering Technologies AG
Price on RequestView Details →
DuvyzatComposition: givinostatItalfarmaco S.p.A.
Price on RequestView Details →
ElevidysComposition: delandistrogene moxeparvovecRoche Registration GmbH
Price on RequestView Details →
ZolgensmaComposition: onasemnogene abeparvovecNovartis Europharm Limited
Price on RequestView Details →

Key Information

Salt / Composition

risdiplam

Category

Other drugs for disorders of the musculo-skeletal system

Manufacturer

Roche Registration GmbH

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.